bleeding during the surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. At least 18 years and less than 65 years old; 2. Properative diagnosed with right colon cancer or gastric cancer who would be treated with right hemicolectomy or D2 radical gastrectomy respectively; 3. There was significant bleeding either in the right colon cuts within the right hemicolectomy or superior pancreas cut within the D2 radical gastrectomy and consequently decided by the investigator to apply the hemostatic gauze; 4. The patient or patient's legally-authorized representative agrees to participate in this study by signing the Ethics Committee (EC)-approved ICF prior to procedure.
Exclusion criteria
Exclusion criteria: 1. Emergency surgery, parenchyma or anastomotic bleeding Active bleeding during the surgery; 2. Serious bleeding-related complications or in any case that investigator decided not to cintunue the study Could not tolerate or refuse blood products or whole blood transfusion; 3. Known or suspected to be allergic to the product orany ingredient (eg, human collagen, fibrinogen, etc.); 4. Coagulation disorders or autoimmune deficiencies; 5. Alcohol or drug abuse; 6. Systemic factors are not conducive to surgery, such as sepsis, or there is any type of serious infectious diseases a month ago before surgery, disseminated intravascular coagulation (dic), or the extensive microvascular bleeding; 7. Suffered from cancer, whose lives are expected less than 3 years. Pregnant or nursing; 8. Another investigational drug or device within 30days patients are poor in compliance and could not complete the follow up as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success of hemostasia in 5 minute;Success of hemostasia in 3 minut; | — |
Secondary
| Measure | Time frame |
|---|---|
| Success of hemostasia in 10 minut; | — |
Countries
China